04.05.2016 • News

Solvay Sells Indupa to Unipar

Foto: zoranm/Getty Images
Foto: zoranm/Getty Images

Solvay has signed a definitive agreement with Brazilian chemical group Unipar Carbocloro to sell its 70.59% stake in Solvay Indupa. The transaction is based on a total enterprise value of $202.2 million, which will be subject to adjustment. Completion is subject to the usual closing conditions, including antitrust approval.

Vincent De Cuyper, a member of Solvay’s executive committee, said the divestment follows the company’s early exit from its European chlorvinyls joint venture with Ineos, which was announced in March 2016.

In acquiring Solvay Indupa, De Cuyper said Unipar will strengthen its strategic position in the caustic soda and chlorine value chain, extending its chemical footprint in PVC and allowing for the company’s further development.

Solvay Indupa has two production sites in Santo André, Brazil, and Bahía Blanca, Argentina, and employs 956 people. The Belgian chemical producer tried to sell Indupa to Braskem in 2014 but the Brazilian competition authority CADE blocked the deal.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read